Proteomic and transcriptomic analysis of heart failure due to volume overload in a rat aorto-caval fistula model provides support for new potential therapeutic targets - monoamine oxidase A and transglutaminase 2

Proteome Science

Volumn 9, Issue , 2011, Pages

  Petrak, Jiri ^a   Pospisilova, Jana ^a   Sedinova, Miroslava ^a   Jedelsky, Petr ^a   Lorkova, Lucie ^a   Vit, Ondrej ^a   Kolar, Michal ^b   Strnad, Hynek ^b   Benes, Jan ^c   Sedmera, David ^a,d   Cervenka, Ludek ^a,c   Melenovsky, Vojtech ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^c INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^d INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Annexins; Heart failure; Hypertrophy; Monoamine oxidase; Transglutaminase

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; ANNEXIN; BIOLOGICAL MARKER; CREATINE KINASE; FATTY ACID; MESSENGER RNA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RYANODINE RECEPTOR 2;

ANIMAL MODEL; ANIMAL TISSUE; AORTOCAVAL FISTULA; ARTICLE; DOWN REGULATION; HEART FAILURE; HEART VOLUME; HEART VOLUME OVERLOAD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; PROTEOMICS; RAT; TRANSCRIPTOMICS; UPREGULATION;

FISTULA; RATTUS; RATTUS NORVEGICUS;

EID: 81055150428     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-9-69     Document Type: Article

References (53)

1. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. Committee for Practice Guidelines (CPG). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Eur J Heart Fail 2008, 10:933-989. 10.1016/j.ejheart.2008.08.005, 18826876.
2. McMurray JJ, Pfeffer MA. Heart failure. Lancet 2005, 365:1877-1889. 10.1016/S0140-6736(05)66621-4, 15924986.
3. Mudd JO, Kass DA. Tackling heart failure in the twenty-first century. Nature 2008, 451:919-928. 10.1038/nature06798, 18288181.
4. Toischer K, Rokita AG, Unsold B, Zhu W, Kararigas G, Sossalla S, Reuter SP, Becker A, Teucher N, Seidler T, Grebe C, Preuss L, Gupta SN, Schmidt K, Lehnart SE, Krüger M, Linke WA, Backs J, Regitz-Zagrosek V, Schäfer K, Field LJ, Maier LS, Hasenfuss G. Differential cardiac remodeling in preload versus afterload. Circulation 2010, 122:993-1003. 10.1161/CIRCULATIONAHA.110.943431, 2955196, 20733099.
5. Trichon BH, Felker GM, Shaw LK, Cabell CH, O'Connor CM. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 2003, 91:538-543. 10.1016/S0002-9149(02)03301-5, 12615256.
6. Garcia R, Diebold S. Simple, rapid, and effective method of producing aortocaval shunts in the rat. Cardiovasc Res 1990, 24:430-432. 10.1093/cvr/24.5.430, 2142618.
7. Flaim SF, Minteer WJ, Nellis SH, Clark DP. Chronic arteriovenous shunt: evaluation of a model for heart failure in rat. Am J Physiol 1979, 236:H698-704.
8. Brower GL, Janicki JS. Contribution of ventricular remodeling to pathogenesis of heart failure in rats. Am J Physiol Heart Circ Physiol 2001, 280:H674-683.
9. Ruzicka M, Yuan B, Leenen FH. Effects of enalapril versus losartan on regression of volume overload-induced cardiac hypertrophy in rats. Circulation 1994, 90:484-491.
10. Ryan TD, Rothstein EC, Aban I, Tallaj JA, Husain A, Lucchesi PA, Dell'Italia LJ. Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload. J Am Coll Cardiol 2007, 49:811-821. 10.1016/j.jacc.2006.06.083, 17306712.
11. Brower GL, Henegar JR, Janicki JS. Temporal evaluation of left ventricular remodeling and function in rats with chronic volume overload. Am J Physiol 1996, 271:H2071-2078.
12. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 1999, 17:994-999. 10.1038/13690, 10504701.
13. Lengqvist J, Uhlen K, Lehtio J. iTRAQ compatibility of peptide immobilized pH gradient isoelectric focusing. Proteomics 2007, 7:1746-1752. 10.1002/pmic.200600782, 17476709.
14. Strnad H, Lacina L, Kolar M, Cada Z, Vlcek C, Dvorankova B, Betka J, Plzak J, Chovanec M, Sachova J, Valach J, Urbanova M, Smetana K. Head and neck squamous cancer stromal fibroblasts produce growth factors influencing phenotype of normal human keratinocytes. Histochem Cell Biol 2010, 133:201-211. 10.1007/s00418-009-0661-6, 19924430.
15. Smyth GK. Limma: linear models for microarray data. Bioinformatics and computational biology solutions using R and Bioconductor 2005, 397-420. New York: Springer, Gentleman V, Careyand S, Dudoid S, Irizarry R, Huber W.
16. Benes J, Melenovsky V, Skaroupkova P, Pospisilova J, Petrak J, Cervenka L, Sedmera D. Myocardial Morphological Characteristics and Proarrhythmic Substrate in the Rat Model of Heart Failure Due to Chronic Volume Overload. Anat Rec (Hoboken) 2011, 294:102-111.
17. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 2005, 85:1093-1129. 10.1152/physrev.00006.2004, 15987803.
18. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev 2010, 90:207-258. 10.1152/physrev.00015.2009, 20086077.
19. Melenovsky V, Benes J, Skaroupkova P, Sedmera D, Strnad H, Kolar M, Vlcek C, Petrak J, Benes J, Papousek F, Oliyarnyk O, Kazdova L, Cervenka L. Metabolic characterization of volume overload heart failure due to aorto-caval fistula in rats. Mol Cell Biochem 2011, 354:83-96. 10.1007/s11010-011-0808-3, 21465236.
20. Jüllig M, Hickey AJ, Middleditch MJ, Crossman DJ, Lee SC, Cooper GJ. Characterization of proteomic changes in cardiac mitochondria in streptozotocin-diabetic rats using iTRAQ™ isobaric tags. Proteomics Clin Appl 2007, 1:565-576. 10.1002/prca.200600831, 21136708.
21. Ingwall JS, Weiss RG. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res 2001, 95:135-145.
22. Dzeja PP, Terzic A. Phosphotransfer networks and cellular energetics. J Exp Biol 2003, 206:2039-2047. 10.1242/jeb.00426, 12756286.
23. Smith CS, Bottomley PA, Schulman SP, Gerstenblith G, Weiss RG. Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation 2006, 114:1151-1158. 10.1161/CIRCULATIONAHA.106.613646, 1808438, 16952984.
24. Bers DM. Altered cardiac myocyte Ca regulation in heart failure. Physiology (Bethesda) 2006, 21:380-387.
25. Takewa Y, Chemaly ER, Takaki M, Liang LF, Jin H, Karakikes I, Morel C, Tatsumi E, Hajjar RJ. Mechanical work and energetic analysis of eccentric cardiac remodeling in a volume overload heart failure in rats. Am J Physiol Heart Circ Physiol 2009, 296:H1117-H1124. 10.1152/ajpheart.01120.2008, 2670699, 19201995.
26. Ding YF, Brower GL, Zhong Q, Murray D, Holland M, Janicki JS, Zhong J. Defective intracellular Ca2+ homeostasis contributes to myocyte dysfunction during ventricular remodelling induced by chronic volume overload in rats. Clin Exp Pharmacol Physiol 2008, 35:827-835. 10.1111/j.1440-1681.2008.04923.x, 18346170.
27. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005, 115:500-508. 1052012, 15765131.
28. Sheeran FL, Rydstrom J, Shakhparonov MI, Pestov NB, Pepe S. Diminished NADPH transhydrogenase activity and mitochondrial redox regulation in human failing myocardium. Biochim Biophys Acta 2010, 1797:1138-1148. 10.1016/j.bbabio.2010.04.002, 20388492.
29. Camors E, Monceau V, Charlemagne D. Annexins and Ca2+ handling in the heart. Cardiovasc Res 2005, 65:793-802. 10.1016/j.cardiores.2004.11.010, 15721859.
30. Bouter A, Gounou C, Berat R, Tan S, Gallois B, Granier T, d'Estaintot BL, Pöschl E, Brachvogel B, Brisson AR. Annexin-A5 assembled into two-dimensional arrays promotes cell membrane repair. Nat Commun 2011, 2:270. 3104517, 21468022.
31. Ravassa S, Gonzalez A, Lopez B, Beaumont J, Querejeta R, Larman M, Díez J. Upregulation of myocardial Annexin A5 in hypertensive heart disease: association with systolic dysfunction. Eur Heart J 2007, 28:2785-2791. 10.1093/eurheartj/ehm370, 17766279.
32. Denzel MS, Scimia MC, Zumstein PM, Walsh K, Ruiz-Lozano P, Ranscht B. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J Clin Invest 2010, 120:4342-4352. 10.1172/JCI43464, 2993592, 21041950.
33. Shibata R, Ouchi N, Murohara T. Adiponectin and cardiovascular disease. Circ J 2009, 73:608-614. 10.1253/circj.CJ-09-0057, 19261992.
34. Mehta K, Fok JY, Mangala LS. Tissue transglutaminase: from biological glue to cell survival cues. Front Biosci 2006, 11:173-185. 10.2741/1789, 16146723.
35. Park D, Choi SS, Ha KS. Transglutaminase 2: a multi-functional protein in multiple subcellular compartments. Amino Acids 2010, 39:619-631. 10.1007/s00726-010-0500-z, 20148342.
36. Song H, Kim BK, Chang W, Lim S, Song BW, Cha MJ, Jang Y, Hwang KC. Tissue transglutaminase 2 promotes apoptosis of rat neonatal cardiomyocytes under oxidative stress. J Recept Signal Transduct Res 2011, 31:66-74. 10.3109/10799893.2010.529577, 21067463.
37. Zhang Z, Vezza R, Plappert T, McNamara P, Lawson JA, Austin S, Praticò D, Sutton MS, Fitzgerald GA. COX-2-dependent cardiac failure in Gh/tTG transgenic mice. Circ Res 2003, 92:1153-1161. 10.1161/01.RES.0000071749.22027.45, 12702643.
38. Small K, Feng JF, Lorenz J, Donnelly ET, Yu A, Yu A, Im MJ, Dorn GW, Liggett SB. Cardiac specific overexpression of transglutaminase II (G(h)) results in a unique hypertrophy phenotype independent of phospholipase C activation. J Biol Chem 1999, 274:21291-21296. 10.1074/jbc.274.30.21291, 10409687.
39. Ou H, Haendeler J, Aebly MR, Kelly LA, Cholewa BC, Koike G, Kwitek-Black A, Jacob HJ, Berk BC, Miano JM. Retinoic acid-induced tissue transglutaminase and apoptosis in vascular smooth muscle cells. Circ Res 2000, 87:881-887.
40. Li X, Wei XL, Meng LL, Chi MG, Yan JQ, Ma XY, Jia YS, Liang L, Yan HT, Zheng JQ. Involvement of tissue transglutaminase in endothelin 1-induced hypertrophy in cultured neonatal rat cardiomyocytes. Hypertension 2009, 54:839-844. 10.1161/HYPERTENSIONAHA.109.130161, 19635990.
41. Eisenhofer G, Kopin IJ, Goldstein DS. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 2004, 56:331-349. 10.1124/pr.56.3.1, 15317907.
42. Bianchi P, Kunduzova O, Masini E, Cambon C, Bani D, Raimondi L, Seguelas MH, Nistri S, Colucci W, Leducq N, Parini A. Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury. Circulation 2005, 112:3297-3305. 10.1161/CIRCULATIONAHA.104.528133, 16286591.
43. Kaludercic N, Takimoto E, Nagayama T, Feng N, Lai EW, Bedja D, Chen K, Gabrielson KL, Blakely RD, Shih JC, Pacak K, Kass DA, Di Lisa F, Paolocci NZ. Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload. Circ Res 2010, 106:193-202. 10.1161/CIRCRESAHA.109.198366, 2804073, 19910579.
44. Kristen AV, Kreusser MM, Lehmann L, Kinscherf R, Katus HA, Haass M, Backs J. Preserved norepinephrine reuptake but reduced sympathetic nerve endings in hypertrophic volume-overloaded rat hearts. J Card Fail 2006, 12:577-583. 10.1016/j.cardfail.2006.05.006, 16952792.
45. Eisenhofer G, Friberg P, Rundqvist B, Quyyumi AA, Lambert G, Kaye DM, Kopin IJ, Goldstein DS, Esler MD. Cardiac sympathetic nerve function in congestive heart failure. Circulation 1996, 93:1667-1676.
46. Menazza S, Blaauw B, Tiepolo T, Toniolo L, Braghetta P, Spolaore B, Reggiani C, Di Lisa F, Bonaldo P, Canton M. Oxidative stress by monoamine oxidases is causally involved in myofiber damage in muscular dystrophy. Hum Mol Genet 2010, 19:4207-4215. 10.1093/hmg/ddq339, 20716577.
47. Kaludercic N, Carpi A, Menabo R, Di Lisa F, Paolocci N. Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury. Biochim Biophys Acta 2011, 1813:1323-1332. 10.1016/j.bbamcr.2010.09.010, 20869994.
48. Riederer P, Lachenmayer L, Laux G. Clinical applications of MAO-inhibitors. Curr Med Chem 2004, 11:2033-2043.
49. Wu Z, Li Y, Li X, Ti D, Zhao Y, Si Y, Mei Q, Zhao P, Fu X, Han W. LRP16 integrates into NF-κB transcriptional complex and is required for its functional activation. PLoS One 2011, 6:e18157. 10.1371/journal.pone.0018157, 3069058, 21483817.
50. Gohil VM, Nilsson R, Belcher-Timme CA, Luo B, Root DE, Mootha VK. Mitochondrial and nuclear genomic responses to loss of LRPPRC expression. J Biol Chem 2010, 285:13742-13747. 10.1074/jbc.M109.098400, 2859537, 20220140.
51. Wang X, Yang Z, Zhang H, Ding L, Li X, Zhu C, Zheng Y, Ye Q. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT. Biochim Biophys Acta 2008, 1783:1220-1228. 10.1016/j.bbamcr.2008.01.026, 18302941.
52. Cooper GJ, Phillips AR, Choong SY, Leonard BL, Crossman DJ, Brunton DH, Saafi L, Dissanayake AM, Cowan BR, Young AA, Occleshaw CJ, Chan YK, Leahy FE, Keogh GF, Gamble GD, Allen GR, Pope AJ, Boyd PD, Poppitt SD, Borg TK, Doughty RN, Baker JR. Regeneration of the heart in diabetes by selective copper chelation. Diabetes 2004, 53:2501-2508. 10.2337/diabetes.53.9.2501, 15331567.
53. Grant JE, Bradshaw AD, Schwacke JH, Baicu CF, Zile MR, Schey KL. Quantification of protein expression changes in the aging left ventricle of Rattus norvegicus. J Proteome Res 2009, 8:4252-4263. 10.1021/pr900297f, 2752960, 19603826.